Partial symptom‐response to proton pump inhibitors in patients with non‐erosive reflux disease or reflux oesophagitis – a post hoc analysis of 5796 patients
Alimentary Pharmacology & Therapeutics2012Vol. 36(7), pp. 635–643
Citations Over TimeTop 10% of 2012 papers
Abstract
Using our conservative definition, partial heartburn response to proton pump inhibitor therapy occurred in 14-20% of gastro-oesophageal reflux disease patients, more commonly in non-erosive reflux disease than in reflux oesophagitis.
Related Papers
- → A randomized comparative study of esomeprazole 40 mg versus pantoprazole 40 mg for healing erosive oesophagitis: the EXPO study(2005)148 cited
- → Intragastric acidity during treatment with esomeprazole 40 mg twice daily or pantoprazole 40 mg twice daily – a randomized, two‐way crossover study(2005)34 cited
- → Oral esomeprazole vs. intravenous pantoprazole: a comparison of the effect on intragastric pH in healthy subjects(2003)28 cited
- → Comparative study of pantoprazole and esomeprazole for erosive gastroesophageal reflux disease: a prospective study(2014)